Accelerating the next generation of immune medicine with cellular proteomics

Join IsoPlexis’ talk to learn how functional phenotyping is addressing urgent challenges central to unlocking the next stage of personalized cancer immunotherapies and vaccines related to immunological mechanisms in infectious disease. With single-cell proteomics barcoding and detection of a full range of cytokines (30+) per single-cell across thousands of single-cells, the IsoLight platform is showing the unique value of resolving the heterogeneity of a variety of immune cell types, elucidating key pre-clinical translational biomarkers to accelerate research and discovery.
In this talk we will show you how functional proteomics can help to :
• Identify functional pathways driving therapeutic resistance and develop combination therapies to combat resistant cell states and resolve tumor heterogeneity
• Understand the functional differences of tumor antigen potency in bi-specifics
• Pinpoint the unique polyfunctional monocyte cell types that drive tumor suppression
• Reveal choice of durable candidates for novel nanoparticle cancer vaccine